Navigation Links
FDA's New Safety Controls for LABA-Containing Drugs Will Impact Prescribing of Single-Agent ICS and LABA/ICS Combination Therapies for the Treatment of Asthma
Date:8/24/2010

WALTHAM, Mass., Aug. 24 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that some surveyed physicians indicate that they will decrease their overall prescribing of long-acting beta2 agonists (LABA)/inhaled corticosteroids (ICS) combination therapies over the next 12 months for the treatment of asthma in response to the U.S. Food and Drug Administration's new safety controls for LABA-containing medications. Most notably, the FDA controls state that LABA/ICS combination medications should be reserved for patients who remain uncontrolled despite treatment with controller medications (e.g., single-agent ICS therapies).

According to the new report entitled Treatment Algorithms in Asthma, more than 40 percent of surveyed physicians report that they will decrease their prescribing of LABA/ICS combinations prior to attempting treatment with a single-agent ICS drug over the next 12 months.

While surveyed physicians indicate that the FDA controls for LABA-containing drugs will affect their decision to prescribe a LABA/ICS combination therapy prior to attempting treatment with a single-agent ICS, surveyed physicians also report that first-line prescribing of LABA/ICS combinations remains common. In particular, surveyed physicians are most likely to prescribe a LABA/ICS combination, such as GlaxoSmithKline's Advair or AstraZeneca's Symbicort, as a first-line maintenance therapy for newly diagnosed adult patients with moderate or severe persistent asthma.

"Some surveyed physicians say they will decrease their use of LABA/ICS combination medications for the treatment of asthma, a trend that may have positive implications for the single-agent ICS class of therapies," said Decision Resources Analyst Martin Quinn. "As a result, marketers of LABA/ICS combination medications and single-agent ICS therapies must focus not only on competitive dyna
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
4. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
5. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
6. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
9. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
10. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... PLAINSBORO, N.J. , April 28, 2015 /PRNewswire-USNewswire/ ... treatments but they also require more of manufacturers, ... Times , the specialty pharmacy field,s premiere journal, ... Pharmacy (NASP), the only national trade association dedicated ... pharmacy businesses and clinicians to fill this growing ...
(Date:4/28/2015)... 28, 2015 The pharmacy information ... million by 2019, growing at a CAGR of 7.7% ... TOC of the pharmacy information systems market, to get ... provides a glimpse of the segmentation of pharmacy information ... by various tables and figures. http://www.micromarketmonitor.com/market-report/pharmacy-information-system-reports-2473565504.html ...
(Date:4/28/2015)... MAHWAH, N.J. , April 28, 2015 ... Tour," Stryker Orthopaedics, is kicking off tournament week by ... the second consecutive year appearing at the tournament, Stryker ... fans about the importance of joint health and mobility. ... Woodlands , Stryker is bringing new features to ...
Breaking Medicine Technology:Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 2Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 3Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 4Pharmacy Information Systems Market is Expected to Reach $3,876.3 Million by 2019, at a CAGR of 7.7% From 2014 to 2019 2Pharmacy Information Systems Market is Expected to Reach $3,876.3 Million by 2019, at a CAGR of 7.7% From 2014 to 2019 3The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 2The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 3The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 4
(Date:4/28/2015)... 28, 2015 MSA Executive Search ... search, announced today that it has been retained to ... Officer search for The Queen's Health Systems ... to QHS President & CEO Arthur A. Ushijima, the ... operating responsibility for the Queen’s Medical Center Punchbowl and ...
(Date:4/28/2015)... A new survey from National Stroke Association reveals ... Americans fear brain damage the most. The results, released ... light on the need for greater awareness of the everyday ... By controlling modifiable risk factors, 80 percent of strokes can ... attack ” that occurs when blood flow to the brain ...
(Date:4/28/2015)... As the Muscular Dystrophy Association continues ... the organization has hired Scientific Program Officer Lianna ... Fidelity Biosciences Research Initiative where, as Associate Director, ... diseases such as Alzheimer’s Disease, and organized and ... Fidelity, she was a junior faculty member at ...
(Date:4/28/2015)... April 28, 2015 Celebrating women has become ... will be the third year that all things mom and ... week. Hands On is offering some great specials ... time of the year could there be to focus on ... deserve pampering and this is a terrific time for it. ...
(Date:4/28/2015)... CA (PRWEB) April 28, 2015 The ... is 2.9 out of 5, indicating a medium level ... means buyers and suppliers have equal power during negotiations. ... substitutes. Rather than purchasing a health insurance policy from ... Corporation or Humana), buyers can choose to self-fund their ...
Breaking Medicine News(10 mins):Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 3Health News:MDA Adds Neurological Disease Expert to Research Team 2Health News:MDA Adds Neurological Disease Expert to Research Team 3Health News:Commack Massage Therapy and Wellness Day Spa Dedicates Time To Celebrate Women 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 4
... KNOXVILLE, Tenn., Feb. 9 Team Health Inc.,s,parent company, ... results for the fiscal year and the fourth quarter ... revenue less provision for uncollectibles ("revenue less provision"),for the ... $1.33 billion,from $1.23 billion in the prior year. Same ...
... Council(R) and H2otStop(R) Launch Burn Awareness Campaign to Teach Families ... WASHINGTON, Feb. 9 New research conducted by the national ... adults in America (82 percent) agree that there are actions ... their home, nearly half (44 percent) say they haven,t done ...
... study suggests , , MONDAY, Feb. 9 (HealthDay News) ... the severity of autism, a new study suggests. ... pinpointed two genes that cause autism-like symptoms in ... more than one gene is involved in people ...
... downside, experts say , , MONDAY, Feb. 9 (HealthDay ... treat chronic obstructive pulmonary disease (COPD) might increase the ... researchers report. , Inhaled corticosteroids, used to treat asthma, ... one product that is marketed by GlaxoSmithKline, Advair, combines ...
... cardiovascular disease, cancer , , MONDAY, Feb. 9 (HealthDay News) ... industry, researchers find no evidence that multivitamin use helps ... top two killers of women, respectively. , "Women can ... to do no harm, but they also seem to ...
... can be used to reliably identify the four known ... Washington University School of Medicine in St. Louis and ... predict the most effective therapy for each breast tumor ... patients., "Unlike a widely used genomic test that applies ...
Cached Medicine News:Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 2Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 3Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 4Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 5Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 6Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 7Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 8Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 9Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 10Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 11Health News:American Families Unaware of Burn Dangers at Home 2Health News:American Families Unaware of Burn Dangers at Home 3Health News:American Families Unaware of Burn Dangers at Home 4Health News:2 Genes Implicated in Autism 2Health News:Inhaled Corticosteroids Boost Pneumonia Risk in COPD 2Health News:Inhaled Corticosteroids Boost Pneumonia Risk in COPD 3Health News:Inhaled Corticosteroids Boost Pneumonia Risk in COPD 4Health News:Vitamins Do Older Women Little Good 2Health News:Vitamins Do Older Women Little Good 3Health News:New genomic test can personalize breast cancer treatment 2Health News:New genomic test can personalize breast cancer treatment 3
... The Small Joint Ball Electrode ... in small joint applications. With its ... tip, controlled capsuloligamentous or tendinous tissue ... When used in conjunction with the ...
... is designed to replace the carpal scaphoid bone. ... pole which fits under a shelf formed in ... suture hole on the proximal hole for suture ... the early postoperative period until a firm capsuloligamentous ...
... Kompressor is a two-piece Titanium (Ti-6Al-4V) screw ... and a variety of lengths. The two ... and sterile packaged. A single instrument set ... removal of both Standard and Mini Kompressor ...
... Total Wrist System was the first wrist implant ... wrist. Since then it has become the leading ... ,During total wrist replacement surgery, doctors remove scar ... replacement implant in place of the damaged wrist. ...
Medicine Products: